Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: Analysis of KIGS (Pfizer international growth database)

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 11, 2004, Pages 5435-5440

  Geffner, Mitchell ^a,h   Lundberg, Michael ^b   Koltowska Häggström, Maria ^b   Abs, Roger ^c   Verhelst, Johan ^d   Erfurth, Eva Marie ^e   Kendall Taylor, Pat ^f   Price, David Anthony ^g   Jonsson, Peter ^b   Bakker, Bert ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b PFIZER INC   (United States)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^d MIDDELHEIM HOSPITAL   (Belgium)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

^g ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^h CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE AGE; CHILD; CONTROLLED STUDY; CRANIOPHARYNGIOMA; DATA BASE; DRUG EFFECT; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PREPUBERTY; PRIORITY JOURNAL; QUALITY OF LIFE; WEIGHT GAIN;

BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CRANIOPHARYNGIOMA; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS;

EID: 8744262948     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0667     Document Type: Article

References (21)

1. Lustig RH 2002 Hypothalamic obesity: the sixth cranial endocrinopathy. Endocrinologist 12:210-217
2. Duff JM, Meyer FB, Ilstrup DM, Laws Jr ER, Schleck CD, Scheithauer BW 2000 Long-term outcomes for surgically resected craniopharyngiomas. Neurosurgery 46:291-302
3. Geffner ME 1996 The growth without growth hormone syndrome. Endocrinol Metab Clin North Am 25:649-663
4. Schoenle EJ, Zapf J, Prader A, Torresani T, Werder EA, Zachmann M 1995 Replacement of growth hormone (GH) in normally growing GH-deficient patients operated for craniopharyngioma. J Clin Endocrinol Metab 80:374-378
5. Bucher H, Zapf J, Torresani T, Prader A, Froesch ER, Illig R 1983 Insulin-like growth factors I and II, prolactin, and insulin in 19 growth hormone-deficient children with excessive, normal, or decreased longitudinal growth after operation for craniopharyngioma. N Engl J Med 309:1142-1146
6. Tiulpakov AN, Mazerkina NA, Brook CG, Hindmarsh PC, Peterkova VA, Gorelyshev SK 1998 Growth in children with craniopharyngioma following surgery. Clin Endocrinol (Oxf) 49:733-738
7. Pinto G, Bussieres L, Recasens C, Souberbielle JC, Zerah M, Brauner R 2000 Hormonal factors influencing weight and growth pattern in craniopharyngioma. Horm Res 53:163-169
8. Roth C, Wilken B, Hanefeld F, Schroter W, Leonhardt U 1998 Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite. Eur J Endocrinol 138:89-91
9. Brennan BM, Rahim A, Blum WF, Adams JA, Eden OB, Shalet SM 1999 Hyperleptinaemia in young adults following cranial irradiation in childhood: growth hormone deficiency or leptin insensitivity? Clin Endocrinol (Oxf) 50: 163-169
10. Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC, Schreiber RE, Rai SN, Lensing SY, Wu S, Xiong X 2003 Octreolide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 88:2586-2592
11. Geffner ME, Lippe BM, Bersch N, Van Herle AJ, Kaplan SA, Elders MJ, Golde DW 1986 Growth without growth hormone: evidence for a potent circulating human growth factor. Lancet 1:343-347
12. Murashita M, Tajima T, Nakae J, Shinohara N, Geffner ME, Fujieda K 1999 Near-normal linear growth in the setting of markedly reduced growth hormone and IGF-I: a case report. Horm Res 51:184-188
13. Bereket A, Lang CH, Geffner ME, Wilson TA 1998 Normal growth in septooptic dysplasia despite both growth hormone and IGF-1 deficiency. J Pediatr Endocrinol Metab 11:69-75
14. Cox JE, Sims JS 1998 Ventromedial hypothalamic and paraventricular nucleus lesions damage a common system to produce hyperphagia. Behav Brain Res 28:297-308
15. Lustig RH, Post SR, Srivannaboon K, Rose SR, Danish RK, Burghen GA, Xiong X, Wu S, Merchant TE 2003 Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab 88:611-616
16. de Vile CJ, Grant DB, Hayward RD, Kendall BE, Neville BG, Stanhope R 1996 Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging. J Clin Endocrinol Metab 81:2734-2737
17. Hogeveen M, Noordam C, Otten B, Wit JM, Massa G 1997 Growth before and during growth hormone treatment in children operated for craniopharyngioma. Horm Res 48:258-262
18. Price DA, Wilton P, Jonsson P, Albertsson-Wikland K, Chatelain P, Cutfield W, Ranke MB 1998 Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996. Horm Res 49:91-97
19. de Vries L, Lazar L, Phillip M 2003 Craniopharyngioma: presentation and endocrine sequelae in 36 children. J Pediatr Endocrinol Metab 16:703-710
20. Srinivisan S, Ogle GD, Garnett SP, Briody JN, Lee JW, Cowell CT 2004 Features of the metabolic syndrome after childhood craniopharyngioma. J Clin Endocrinol Metab 89:81-86
21. Muller HL, Bueb K, Bartels U, Roth C, Harz K, Graf N, Korinthenberg R, Bettendorf M, Kuhl J, Gutjahr P, Sorensen N, Calaminus G 2001 Obesity after childhood craniopharyngioma: German multicenter study on pre-operative risk factors and quality of life. Klin Padiatr 213:244-249